PF-Atlas › Clinical Trials › NCT03242759

Non-Interventional Study Collecting Experiences For IPF in Taiwan

nintedanib · Not specified

Registry ID
NCT03242759
Phase
Not specified
Status
Completed
Drug / intervention
nintedanib
Sponsor
Boehringer Ingelheim
Start
2017-08-17

About this trial

nintedanib is evaluated in NCT03242759, a idiopathic pulmonary fibrosis study sponsored by Boehringer Ingelheim. Current status: Completed.

View NCT03242759 on ClinicalTrials.gov →

Explore related

All nintedanib trialsAll IPF trials

Related trials

nintedanib — NCT02606877Nintedanib — NCT02598193Nintedanib — NCT02579603Nintedanib — NCT02597933Nintedanib — NCT02999178Nintedanib — NCT02607722
Medical disclaimer. This page summarizes public trial data for NCT03242759 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.